[
  {
    "ts": null,
    "headline": "Analyst Upgrades Signal Renewed Growth Cycle for Edwards Lifesciences Corporation (EW)",
    "summary": "Edwards Lifesciences Corporation (NYSE:EW) is one of the best healthcare stocks to buy for 2026. On January 20, Stifel raised its price target of Edwards Lifesciences Corporation (NYSE:EW) to $110 from $105 while reiterating a Buy rating. The price target hike is in response to a significant increase in the number of Transcatheter Aortic Valve […]",
    "url": "https://finnhub.io/api/news?id=7ea217df25dec17f5d5f46e47ba335f5cb10034d054e8297fe378a51e4441282",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769870157,
      "headline": "Analyst Upgrades Signal Renewed Growth Cycle for Edwards Lifesciences Corporation (EW)",
      "id": 138315854,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Edwards Lifesciences Corporation (NYSE:EW) is one of the best healthcare stocks to buy for 2026. On January 20, Stifel raised its price target of Edwards Lifesciences Corporation (NYSE:EW) to $110 from $105 while reiterating a Buy rating. The price target hike is in response to a significant increase in the number of Transcatheter Aortic Valve […]",
      "url": "https://finnhub.io/api/news?id=7ea217df25dec17f5d5f46e47ba335f5cb10034d054e8297fe378a51e4441282"
    }
  }
]